AKRO - Abraham Fruchter & Twersky LLP Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of Akero Therapeutics Inc. (NYSE: AKRO) | Benzinga
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nationally recognized law firm that focuses on protecting investors' rights, informs shareholders of a class action lawsuit on behalf of investors who purchased Akero Therapeutics, Inc. ("Akero") (NYSE:AKRO) common stock captioned Klobus v. Akero Therapeutics, Inc., No. 3:24-cv-02534 (N.D. Cal.).
The Akero class action lawsuit alleges violations of the federal securities laws, including making false and misleading statements by Akero Inc. and its directors and officers. The class action lawsuit is brought on behalf of purchasers and acquirers of Akero's publicly traded securities between September 13, 2022, and October 9, 2023, inclusive (the "Class Period").
The Akero class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading ...
AKRO)>Full story available on Benzinga.com